Tech Company Financing Transactions

AsclepiX Therapeutics Funding Round

AsclepiX Therapeutics, operating out of Baltimore, scored $5 million from Barer & Son Capital, Piedmont Angel Network and Rapha Capital Management.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Proceeds Purpose
With this investment, AsclepiX will accelerate development of AXT107, its innovative treatment for two leading causes of adult blindness: diabetic macular edema (DME) and wet age-related macular degeneration (wet AMD).

Company Information

Company Status
Private & Independent
Mailing Address
301 West 29th St. 2004
Baltimore, MD 21211
Email Address
AsclepiX Therapeutics is focussed on transforming the treatment of retinal disease and cancer through the rapid clinical development of groundbreaking therapies which may empower patients and families around the world with the freedom to live their best lives.
AsclepiX Therapeutics LinkedIn Company Profile
Social Media
AsclepiX Therapeutics Company Twitter Account
Company News
AsclepiX Therapeutics News
AsclepiX Therapeutics on Facebook
AsclepiX Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Kevin Slawin
  Kevin Slawin LinkedIn Profile  Kevin Slawin Twitter Account  Kevin Slawin News  Kevin Slawin on Facebook
Chief Medical Officer
Theresa Heah
  Theresa Heah LinkedIn Profile  Theresa Heah Twitter Account  Theresa Heah News  Theresa Heah on Facebook
Chief Scientific Officer
Aleksander Popel
  Aleksander Popel LinkedIn Profile  Aleksander Popel Twitter Account  Aleksander Popel News  Aleksander Popel on Facebook
Chief Technical Officer
Jordan Green
  Jordan Green LinkedIn Profile  Jordan Green Twitter Account  Jordan Green News  Jordan Green on Facebook
VP - R & D
Niranjan Pandey
  Niranjan Pandey LinkedIn Profile  Niranjan Pandey Twitter Account  Niranjan Pandey News  Niranjan Pandey on Facebook
VP - R & D
Huan Sheng
  Huan Sheng LinkedIn Profile  Huan Sheng Twitter Account  Huan Sheng News  Huan Sheng on Facebook



Browse more venture capital transactions:

Prev: 11/14/2018: NextCure venture capital transaction
Next: 11/14/2018: Netskope venture capital transaction


Share this article


Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary